These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 24926638)

  • 1. [Antidepressants and tamoxifen: an unrecognized interaction].
    Moulis M; Khouri C; Mallaret M
    Therapie; 2014; 69(2):178-9. PubMed ID: 24926638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between tamoxifen and antidepressants via cytochrome P450 2D6.
    Desmarais JE; Looper KJ
    J Clin Psychiatry; 2009 Dec; 70(12):1688-97. PubMed ID: 20141708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do some antidepressants decrease effect of tamoxifen?
    J Support Oncol; 2009; 7(4):147-8. PubMed ID: 19731582
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antagonism of tamoxifen and antidepressants among women with breast cancer].
    Irarrázaval O ME
    Rev Med Chil; 2011 Jan; 139(1):89-99. PubMed ID: 21526323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unjustified prescribing of CYP2D6 inhibiting SSRIs in women treated with tamoxifen.
    Binkhorst L; Mathijssen RH; van Herk-Sukel MP; Bannink M; Jager A; Wiemer EA; van Gelder T
    Breast Cancer Res Treat; 2013 Jun; 139(3):923-9. PubMed ID: 23760858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SSRIs and tamoxifen. Why condemn fluoxetine?
    Jenkinson ML
    BMJ; 2010 Mar; 340():c1319. PubMed ID: 20219794
    [No Abstract]   [Full Text] [Related]  

  • 7. Antidepressants and tamoxifen: interaction concerns.
    Cass-Verco J; Mason C; Wilcken N
    Australas Psychiatry; 2013 Oct; 21(5):508-9. PubMed ID: 24085721
    [No Abstract]   [Full Text] [Related]  

  • 8. Some antidepressants interfere with tamoxifen more than others.
    Harv Womens Health Watch; 2010 Mar; 17(7):6. PubMed ID: 20480970
    [No Abstract]   [Full Text] [Related]  

  • 9. How often did Belgian physicians co-prescribe tamoxifen with strong CYP2D6 inhibitors over the last 6 years?
    Dieudonné AS; De Nys K; Casteels M; Wildiers H; Neven P
    Acta Clin Belg; 2014; 69(1):47-52. PubMed ID: 24635399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do antidepressants reduce the effectiveness of tamoxifen?
    Breitbart W
    Psychooncology; 2011 Jan; 20(1):1-4. PubMed ID: 21182159
    [No Abstract]   [Full Text] [Related]  

  • 11. Tamoxifen-SSRIs interaction: clinical manifestations of inhibition and lack of inhibition of CYP2D6.
    Appiani F; Carroll BT; Muñoz C; Trecco J
    Ann Clin Psychiatry; 2011 May; 23(2):152-3. PubMed ID: 21547277
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antidepressants agents in breast cancer patients using tamoxifen: review of basic and clinical evidence].
    Irarrázaval O ME; Gaete G L
    Rev Med Chil; 2016 Oct; 144(10):1326-1335. PubMed ID: 28074989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen and Potent CYP2D6 Inhibitors: A Potentially Lethal Interaction.
    Battley J E ; O'Connor M ; Barron T I ; O'Reilly S
    Ir Med J; 2015 Jun; 108(6):188-9. PubMed ID: 26182810
    [No Abstract]   [Full Text] [Related]  

  • 14. Trends in co-prescribing of antidepressants and tamoxifen among women with breast cancer, 2004-2010.
    Dusetzina SB; Alexander GC; Freedman RA; Huskamp HA; Keating NL
    Breast Cancer Res Treat; 2013 Jan; 137(1):285-96. PubMed ID: 23149465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent CYP2D6 Inhibiting drugs do not increase relapse rate in early breast cancer patients treated with adjuvant tamoxifen.
    Siegelmann-Danieli N; Kurnik D; Lomnicky Y; Vesterman-Landes J; Katzir I; Bialik M; Loebstein R
    Breast Cancer Res Treat; 2011 Jan; 125(2):505-10. PubMed ID: 20593233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study.
    Kelly CM; Juurlink DN; Gomes T; Duong-Hua M; Pritchard KI; Austin PC; Paszat LF
    BMJ; 2010 Feb; 340():c693. PubMed ID: 20142325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-prescription of metoprolol and CYP2D6-inhibiting antidepressants before and after implementation of an optimized drug interaction database in Norway.
    Gedde-Dahl A; Spigset O; Molden E
    Eur J Clin Pharmacol; 2022 Oct; 78(10):1623-1632. PubMed ID: 35871665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of concomitant CYP2D6 inhibitor use and tamoxifen adherence on breast cancer recurrence in early-stage breast cancer.
    Dezentjé VO; van Blijderveen NJ; Gelderblom H; Putter H; van Herk-Sukel MP; Casparie MK; Egberts AC; Nortier JW; Guchelaar HJ
    J Clin Oncol; 2010 May; 28(14):2423-9. PubMed ID: 20385997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer recurrence in relation to antidepressant use.
    Chubak J; Bowles EJ; Yu O; Buist DS; Fujii M; Boudreau DM
    Cancer Causes Control; 2016 Jan; 27(1):125-36. PubMed ID: 26518198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Avoidance of CYP2D6 inhibitors in patients receiving tamoxifen.
    Ferraldeschi R; Howell SJ; Thompson AM; Newman WG
    J Clin Oncol; 2010 Oct; 28(29):e584-5; author reply e586. PubMed ID: 20823421
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.